Chih Ming Chen is a notable inventor based in Davie, Florida. He has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. His work primarily focuses on controlled release oral dosage forms, which are crucial for improving medication efficacy and patient compliance.

Latest Patents

Among his latest patents, Chen has developed a once-a-day bupropion salt formulation. This innovation aims to enhance the therapeutic effects of bupropion while minimizing side effects. Additionally, he has also patented a once-a-day bupropion hydrochloride formulation, further demonstrating his commitment to advancing pharmaceutical formulations.

Career Highlights

Chih Ming Chen is currently employed at Andrx Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical industry. His expertise in controlled release formulations has positioned him as a key player in developing effective medication delivery systems.

Collaborations

Chen has collaborated with esteemed colleagues such as Avinash Nangia and Boyong Li. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Chih Ming Chen's contributions to pharmaceutical innovations through his patents and collaborations highlight his significant role in the industry. His work continues to impact the way medications are formulated and delivered to patients.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com